Does Rallies summarize VTIX news?

Yes. Rallies summarizes VTIX news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.

Is VTIX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VTIX. It does not provide personalized investment advice.

VTIX (Virtuix Holdings Inc. Class A Common Stock) Stock Analysis - News

Virtuix Holdings Inc. Class A Common Stock (VTIX) is a publicly traded the market company. As of May 20, 2026, VTIX trades at $3.40 with a market cap of $124.02M and a P/E ratio of 0.00. VTIX moved +1.17% today. Year to date, VTIX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $3.14 to $92.74. Rallies surfaces VTIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in VTIX news today?

Virtuix Partners with Rutgers to Explore AI-Driven Autism Therapy on Omni One: Rutgers University deployed Virtuix’s Omni One treadmill to research AI-assisted neurodivergent therapy and autism interventions using movement-centered XR and immersive behavioral analytics. The autism spectrum disorder treatment market is expected to expand from $9.2 billion in 2026 to over $18 billion by 2034 at a 9% CAGR.

VTIX Key Metrics

Key financial metrics for VTIX
Metric	Value
Price	$3.40
Market Cap	$124.02M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$92.74
52-Week Low	$3.14
Volume	114.97K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Latest VTIX News

Virtuix Partners with Rutgers to Explore AI-Driven Autism Therapy on Omni One — May 20, 2026
Virtuix Launches Omni One VR Systems in Canada After 41% Revenue Surge — May 12, 2026
Virtuix Secures U.S. Marine Corps VR Contract Featuring Four Omni One Treadmills — May 5, 2026
Virtuix Secures 26th U.S. Patent for Omni One Treadmill Design — Apr 30, 2026
Virtuix Integrates Omni One into Marine Corps FARP Simulator, Expands Defense Reach — Apr 28, 2026

Recent VTIX Insider Trades

Goetgeluk Jan Roger sold 20.28K (~$72.60K) on May 6, 2026.
Goetgeluk Jan Roger sold 77.43K (~$312.83K) on May 5, 2026.
Goetgeluk Jan Roger sold 24.18K (~$84.62K) on May 4, 2026.

VTIX Analyst Consensus

VTIX analyst coverage data. Average price target: $0.00.

Common questions about VTIX

What changed in VTIX news today?: Virtuix Partners with Rutgers to Explore AI-Driven Autism Therapy on Omni One: Rutgers University deployed Virtuix’s Omni One treadmill to research AI-assisted neurodivergent therapy and autism interventions using movement-centered XR and immersive behavioral analytics. The autism spectrum disorder treatment market is expected to expand from $9.2 billion in 2026 to over $18 billion by 2034 at a 9% CAGR.
Does Rallies summarize VTIX news?: Yes. Rallies summarizes VTIX news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is VTIX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VTIX. It does not provide personalized investment advice.